계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Vascudyne
company
About
Vascudyne is developing, manufacturing, and commercializing regenerative acellular in-vitro grown “allograft” tissue.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology,Life Science,Medical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Vascudyne is developing, manufacturing, and commercializing regenerative acellular in-vitro grown “allograft” tissue.Vascudyne is the world's leading center of excellence for developing and manufacturing engineered tissue. We provide our clients with world-class engineered tissue, unique engineered tissue-based device designs, manufacturing capabilities, technical expertise, and product development support.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Vascudyne has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
May 10, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 10, 2022 | Grant | — | 1 |
Regenerative Medicine Minnesota
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Vascudyne is funded by 1 investors.
Regenerative Medicine Minnesota
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Regenerative Medicine Minnesota
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
